Ketamine Clinic in Japan for Inbound Medical Treatment: Nagoya Anesthesia Clinic
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
NAGOYA, Japan -- Businesswire -- Nagoya Anesthesia Clinic (https://nagoyamasui.com/2-2), located in Nagoya City, Aichi Prefecture, Japan, has initiated inbound medical treatment for treatment-resistant depression, other mental disorders, and intractable chronic pain, utilizing the groundbreaking drug Ketamine. Over the past 15 years, the clinic has provided ketamine therapy through more than 1300 ketamine infusions. Our distinctive approach to addressing pain and depression includes a simultaneous cervical epidural block, with successful implementation in over 250 cases, and hypnotherapy during ketamine infusion. Additionally, the clinic offers innovative procedures such as Echo-Guided Botox treatment for stiff neck and Echo-Guided PRP therapy for tennis elbow.
Ketamine, a widely used general anesthetic with a history dating back over 50 years, has also been employed in the United States for the treatment of mental disorders and chronic pain for the past decade. Unlike conventional medications, which may take time to alleviate symptoms, Ketamine offers rapid relief within hours to up to three weeks of administration. Moreover, it is associated with minimal long-term side effects, making it a promising treatment option.
Drawing on their extensive experience of performing Ketamine infusions for various pain and mental disorders, Nagoya Anesthesia Clinic has established the Ketamine Clinic based on Ketamine's potent analgesic and antidepressant properties. Typically, ketamine infusions are administered in sets of 3 to 6 sessions over a span of 1 to 3 weeks, followed by a maintenance therapy once a month, known for its low incidence of long-term side effects.
Nagoya Anesthesia Clinic is dedicated to provision of exceptional care and innovative treatments to patients in Japan and beyond, welcoming patients for inbound medical treatment of treatment-resistant depression, OCD, PTSD, and intractable chronic pain starting from October 2023. Building on their extensive ketamine infusion experience, the clinic aims to support individuals coping with treatment-resistant conditions through innovative, evidence-based, and compassionate approaches.
· Nagoya Anesthesia Clinic “Ketamine Clinic” Information Page: https://nagoyamasui.com/ketamine3
· “Stiff Neck Botox” Information Page: https://nagoyamasui.com/botox3
· “Tennis Elbow PRP Therapy” Information Page: https://nagoyamasui.com/prp3
View source version on businesswire.com: https://www.businesswire.com/news/home/20231113434750/en/
이 뉴스는 기업·기관·단체가 뉴스와이어를 통해 배포한 보도자료입니다.
출처:Nagoya Anesthesia Clinic
보도자료 통신사 뉴스와이어(www.newswire.co.kr) 배포
Copyright © 뉴스와이어. 무단전재 및 재배포 금지.
- 헤비메탈의 거장 ‘잉베이 맘스틴’ 40주년 기념 서울 내한 공연 12월 18일 개최 - 뉴스와이어
- 라이노스 ‘소음·가격’ 다 잡은 3세대 산소발생기 ‘휠리O2’ 출시 - 뉴스와이어
- 현대자동차, 2025 아이오닉 5 N 출시 - 뉴스와이어
- 오데마 피게, 로열 오크 콘셉트 컬렉션에서 새로운 단조 카본 첫 공개 - 뉴스와이어
- 숯불 함박스테이크 전문점 골드버그, SBS 생방송 투데이 출연 - 뉴스와이어
- LS일렉트릭, 베트남 ‘2024 일렉트릭에너지쇼’ 참가 - 뉴스와이어
- ‘2024년 춘천 애니·토이 한마당’ 개최 - 뉴스와이어
- KG 모빌리티, 2024 미래 모빌리티 테크쇼 개최 - 뉴스와이어
- 미아리고개예술극장, 연극 ‘생활의 비용’ 재공연 - 뉴스와이어
- 기아, 일본 PBV 시장 진출 - 뉴스와이어